Literature DB >> 25160064

Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): a randomized controlled trial.

Jerome Ateudjieu1, Beat Stoll2, Georges Nguefack-Tsague3, Christoph Tchangou4, Blaise Genton5.   

Abstract

BACKGROUND: To ensure vaccines safety, given the weaknesses of the national pharmacovigilance system in Cameroon, there is a need to identify effective interventions that can contribute to improving AEFI reporting.
OBJECTIVE: To assess the effect of: (i) sending weekly SMS, or (ii) weekly supervisory visits on AEFI reporting rate during a meningitis immunization campaign conducted in Cameroon in 2012 using the meningitis A conjugate vaccine (MenAfriVac™).
METHODS: Health facilities that met the inclusion criteria were randomly assigned to receive: (i) a weekly standardized SMS, (ii) a weekly standardized supervisory visits or (iii) no intervention. The primary outcome was the reported AEFI incidence rate from week 5 to 8 after the immunization campaign. Poisson regression model was used to estimate the effect of interventions after adjusting for health region, type of health facility, type and position of health workers as well as the cumulative number of AEFI reported from weeks 1 to 4.
RESULTS: A total of 348 (77.2%) of 451 health facility were included, and 116 assigned to each of three groups. The incidence rate of reported AEFI per 100 health facility per week was 20.0 (15.9-24.1) in the SMS group, 40.2 (34.4-46.0) in supervision group and 13.6 (10.1-16.9) in the control group. Supervision led to a significant increase of AEFI reporting rate compared to SMS [adjusted RR=2.1 (1.6-2.7); p<0.001] and control [RR=2.8(2.1-3.7); p<0.001)] groups. The effect of SMS led to some increase in AEFI reporting rate compared to the control group, but the difference was not statistically significant [RR=1.4(0.8-1.6); p=0.07)].
CONCLUSION: Supervision was more effective than SMS or routine surveillance in improving AEFI reporting rate. It should be part of any AEFI surveillance system. SMS could be useful in improving AEFI reporting rates but strategies need to be found to improve its effectiveness, and thus maximize its benefits.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AEFI surveillance; Cameroon; Immunization campaign; MenAfriVac™; Meningitis vaccine; SMS; supervision

Mesh:

Substances:

Year:  2014        PMID: 25160064     DOI: 10.1016/j.vaccine.2014.08.012

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  The Effect of Text Message Reminders to Health Workers on Quality of Care for Malaria, Pneumonia, and Diarrhea in Malawi: A Cluster-Randomized, Controlled Trial.

Authors:  Laura C Steinhardt; Don P Mathanga; Dyson Mwandama; Humphreys Nsona; Dubulao Moyo; Austin Gumbo; Miwako Kobayashi; Ruth Namuyinga; Monica P Shah; Andy Bauleni; Peter Troell; Dejan Zurovac; Alexander K Rowe
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

2.  Safety profile of the meningococcal conjugate vaccine (Menafrivac™) in clinical trials and vaccination campaigns: a review of published studies.

Authors:  Jerome Ateudjieu; Beat Stoll; Anne Cecile Bisseck; Ayok M Tembei; Blaise Genton
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

3.  Factors associated with the exposure of vaccines to adverse temperature conditions: the case of North West region, Cameroon.

Authors:  Martin Ndinakie Yakum; Jérôme Ateudjieu; Fida Ramsina Pélagie; Ebile Akoh Walter; Pierre Watcho
Journal:  BMC Res Notes       Date:  2015-06-30

4.  Improving community based AEFI (Adverse Events Following Immunization) reporting rate through telephone "beep" in a Cameroon health district: a randomized field trial.

Authors:  Marcellin Tsafack; Jérôme Ateudjieu
Journal:  Pan Afr Med J       Date:  2015-12-11

Review 5.  Participant-centred active surveillance of adverse events following immunisation: a narrative review.

Authors:  Patrick Cashman; Kristine Macartney; Gulam Khandaker; Catherine King; Michael Gold; David N Durrheim
Journal:  Int Health       Date:  2017-05-01       Impact factor: 2.473

6.  Mobile technologies to support healthcare provider to healthcare provider communication and management of care.

Authors:  Daniela C Gonçalves-Bradley; Ana Rita J Maria; Ignacio Ricci-Cabello; Gemma Villanueva; Marita S Fønhus; Claire Glenton; Simon Lewin; Nicholas Henschke; Brian S Buckley; Garrett L Mehl; Tigest Tamrat; Sasha Shepperd
Journal:  Cochrane Database Syst Rev       Date:  2020-08-18

7.  Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015.

Authors:  Jiayao Lei; Madhava Ram Balakrishnan; Jane F Gidudu; Patrick L F Zuber
Journal:  Vaccine       Date:  2018-02-14       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.